00136

Cat.No.: CSC-C9485J

Species: Human

Specification
Q & A
Customer Review

Cat.No.

CSC-C9485J

Description

An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen (HLA)-typing data available.

Species

Human

Tissue of Origin

Blood

Recommended Medium

RPMI 1640 + 2mM Glutamine + 10% Fetal Bovine Serum (FBS) To help establish a culture the concentration of FBS can be increased to 20%.

Storage

Liquid Nitrogen (-180 °C).

Storage and Shipping

Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cryopreserved cells be kept at -20 °C.

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Are there specific testing techniques recommended for quality control of tumor cells?

Recommended testing techniques include DNA profiling, karyotyping, mycoplasma testing, and monitoring growth curves.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

Versatile tumor cell products

I appreciate the versatility of the tumor cell product I purchased. Whether it's studying tumor progression, metastasis, or drug resistance, these cells perform exceptionally well.

06 Jan 2024

Ease of use
After sales services
Value for money

Write your own review

CAL-39

Description: Established from the primary lesion resected from a 76-year-old woman with bulky, moderately differentiated squamous cell carcinoma of the vulva in 1984; cells were reported to express an elevated number of high affinity EGF receptors, to carry gene amplification at 11q13 and to be tumorigenic in nude mice

Cat#: CSC-C0316 INQUIRY

View Product

EGI-1

Description: Established from the solid tumor of a 52-year-old Caucasian man with advanced stage malignant bile duct carcinoma (patient had not received any chemotherapy prior to cell explantation) in 1984 and three consecutive passages in female nu/nu mice (NMRI); primary tumor histology: large cell adenocarcinoma of low differentiation, metastasizing (ascites in patient); human character of cell line confirmed by karyotype in passage #34 of in vitro culture (1986)

Cat#: CSC-C0433 INQUIRY

View Product

AC-1M81

Description: Subclone of ACH1P which was established by fusion of the JEG-3-derived HGPRT-defective mutant cell line AC1-1 with primary male trophoblast cells isolated from term human chorion laeve; described as possessing both, a distinct karyotype and a distinct expression pattern of tumor-related genes

Cat#: CSC-C0485 INQUIRY

View Product

AC-1M88

Description: One of five phenotypically and cytogenetically distinct subclones of a hybrid (ACH1P) formed by fusing an HGPRT-defective mutant (AC1-1) of JEG-3 human choriocarcinoma with primary human trophoblast (chorion laeve) cells

Cat#: CSC-C0486 INQUIRY

View Product

ACH1P

Description: Established by somatic hybridization of primary male trophoblast cells and the HGPRT-defective choriocarcinoma cell line AC1-1 which was originally derived from cell line JEG-3

Cat#: CSC-C0496 INQUIRY

View Product

NTERA-2

Description: NTERA-2 was cloned from cell line TERA-2 which was derived from a metastatic teratocarcinoma of a 22-year-old Caucasian male; cell line also known as NT-2

Cat#: CSC-C0535 INQUIRY

View Product

For research use only. Not for any other purpose.